Samwise Healthcare IT Newsletter
Tuesday, July 21, 2026
BMS and NVIDIA Build an ‘AI Factory’ for Drug Discovery
Bristol Myers Squibb and NVIDIA announced a partnership to build an ‘AI factory’ dedicated to accelerating drug discovery. The pharmaceutical giant will deploy NVIDIA’s DGX SuperPOD infrastructure, powered by DGX Vera Rubin NVL72 systems, integrating massive computational power directly into BMS’s research workflows. Greg Meyers, BMS Chief Digital and Technology Officer, said the deployment transforms how the company approaches early-stage discovery, enabling researchers to rapidly model molecular interactions and screen drug candidates at unprecedented scale. The collaboration represents a broader industry push to industrialize AI for pharmaceutical R&D — moving beyond one-off experiments toward a continuous, high-throughput pipeline that can shorten the path from lab hypothesis to clinical trial.
Sources: MobiHealthNews Share ↗ ✉︎ Email 💬 Text
Tempus to Acquire Cancer Genomics Company Personalis for $1.5B
Tempus AI announced it will acquire cancer genomics company Personalis in a deal valued at approximately $1.5 billion, deepening the AI data company’s precision oncology capabilities. Personalis shareholders will receive $16.25 per share — primarily in Tempus stock — representing a 28% premium over the unaffected 30-day average. The acquisition integrates Personalis’ NeXT Personal platform, which uses whole-genome sequencing to create a personalized genetic signature from a patient’s tumor, into Tempus’ AI-driven oncology suite. CEO Eric Lefkofsky called molecular residual disease testing ‘a large and rapidly growing market.’ Shares of both companies fell sharply following the announcement, with Tempus dropping about 9%.
Sources: MobiHealthNews Share ↗ ✉︎ Email 💬 Text
Inside Epic’s ‘Agent Factory’: Real-World Results From Advocate and ECU Health
Health systems warn that AI agent readiness requires more than enthusiasm — it demands data governance, team expertise and disciplined workflow design. Two Epic customers, Advocate Health and ECU Health, shared early results from Epic’s new Agent Factory platform, which enables no-code deployment of autonomous agents directly within the EHR. Advocate, one of the nation’s largest Epic users, launched agents for inpatient pharmacy verification and infusion chart prep. ECU Health’s Transfer Center agent — deployed with just 14 staff — eliminated approximately 20 hours of chart review per week in its first month. Both organizations reported that overnight prompt refinements were essential to achieving clinician acceptance.
Sources: Healthcare IT News Share ↗ ✉︎ Email 💬 Text
DaVita’s CIO on Making One Billion Data Points Work Harder for Kidney Patients
DaVita Chief Information Officer Madhu Narasimhan says the kidney care provider’s digital transformation hinges on putting the right information in front of clinicians at the right moment — not simply collecting more data. With more than a billion data points generated annually from roughly 30 million treatments, DaVita’s Center Without Walls platform integrates clinical, operational and patient-generated information into a longitudinal record. Connected home dialysis devices feed real-time signals that allow care teams to intervene earlier between visits. AI tools synthesize lab results, hospitalization histories and clinical notes into concise decision-support summaries, while predictive models identify patients at risk of discontinuing home dialysis before problems escalate.
Sources: Healthcare IT News Share ↗ ✉︎ Email 💬 Text
‘Bad Data at AI Speed Is Still Bad Data’ — A Warning From the Quality Trenches
Health IT leaders rushing to deploy AI are overlooking a foundational problem, warns Troy Heninger, director of data governance and data quality at St. Luke’s Boise Medical Center. ‘Bad data at AI speed is still bad data. It simply moves faster and at far greater scale.’ St. Luke’s — which holds HIMSS Stage 6 recognition for analytics maturity — treats governance as a strategic priority, not a compliance exercise. Heninger argues that AI initiatives require business glossaries, common standards and stewardship before any model goes live: ‘AI systems can infer patterns, but they do not independently determine whether data is accurate, contextually appropriate or fit for a high-stakes use case.’
Sources: Healthcare IT News Share ↗ ✉︎ Email 💬 Text
Craneware and Abbott Probe Separate Healthcare Data Theft Incidents
Two major healthcare-sector cybersecurity incidents are under investigation following separate data theft disclosures. Healthcare software firm Craneware — whose billing, pricing and pharmacy tools serve approximately 2,000 U.S. hospitals — confirmed that ‘a significant volume’ of customer and employee data was exfiltrated in an unauthorized access incident. Craneware has engaged external forensic experts and says the breach is now contained without disruption to customer services. Separately, Abbott Laboratories is probing unauthorized access to internal systems in its Cancer Diagnostics business, even as cybercriminals ShinyHunters and ShadowByt3$ publicly claim far more extensive access than the company acknowledges. Both incidents underscore the growing threat to healthcare sector third-party vendors.
Sources: GovInfoSecurity Share ↗ ✉︎ Email 💬 Text
Curated by JD · samwise.agency
Leave a Reply
You must be logged in to post a comment.